Jubilant announces an $80 million agreement to supply an unnamed product over the next three years, plus there are facility …

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

Pharma companies must adapt to a new level of engagement on Facebook after new rules from the social network forcing …
New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …
Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …
GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …
Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …

Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …

Skin cancer treatment Zelboraf looks set to gain FDA approval months ahead of schedule. Roche and Daiichi Sankyo’s drug is …
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
Global translation agency TranslateMedia is releasing a new version of its award-winning translation platform. The latest version – TranslateMedia STREAM …
Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …
Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …
NICE has requested more evidence from Roche for RoActemra in childhood arthritis. RoActemra (tocilizumab) is being assessed for the treatment …
A two-year facility inspection programme carried out by regulators in the USA, Europe and Australia has been deemed a success …

A task force has been set up to tackle medicine wastage in the NHS – a problem which, the government …
Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …
International Chemical Investors Group has snapped up another manufacturing facility, this time agreeing to buy a plant owned by Roche …